Eudaimonia Asset Management »

Silverback Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.8M 262k 14.50
2023-03-31 $1.2M 10k 120.97
2022-12-31 $1.1M 125k 8.53

More positions owned by Eudaimonia Asset Management

FTAI Aviation Common Stock (FTAI)
Vaxcyte Common Stock (PCVX)
Sprouts Farmers Market Common Stock (SFM)
Insmed Common Stock (INSM)
CommVault Systems Common Stock (CVLT)
Zeta Global Holdings Corp Common Stock (ZETA)
Cava Group Common Stock (CAVA)
Ensign Group Inc/The Common Stock (ENSG)
Modine Manufacturing Common Stock (MOD)
ACI Worldwide Common Stock (ACIW)
Lantheus Holdings Common Stock (LNTH)
Piper Sandler Cos Common Stock (PIPR)
Glaukos Corp Common Stock (GKOS)
UFP Technologies Common Stock (UFPT)
StepStone Group Common Stock (STEP)

View all positions for Eudaimonia Asset Management

Top funds holding Silverback Therapeutics

Deerfield Management Company
RA Capital Management
OrbiMed Advisors
BlackRock
Sr One Capital Management
Vanguard Group
Franklin Resources
State Street Corporation
Geode Capital Management
Nextech Invest
FMR
Woodline Partners
Royce & Associates
Jacobs Levy Equity Management
First Turn Management

View all funds holding Silverback Therapeutics